The EFORT official statements webpage provides official l statements from senior European orthopaedic ad traumatology specialists as they report on developments, news and technology affecting the European orthopaedic and trauma community.

New Medical Devices Regulations (MDR) and In Vitro Diagnostic Medical Devices Regulations (IVDR)

EFORT calls upon the European Commission and European Parliament to ensure that implementation of the new Medical Devices Regulations (MDR) and In Vitro Diagnostic Medical Devices Regulations (IVDR) does not jeopardise the availability of high quality medical devices, which enable the safe treatment of patients and avoid compromised outcomes. EFORT is the European Federation of […]

Cobalt in Orthopaedic Implants

Joint Statement of EFORT and MedTech Europe’s Orthopaedic Sector Group 14 August 2018 Under the new Medical Devices Regulation, orthopaedic implants containing Cobalt (usually in alloy form) will most likely have to bear a label communicating the presence of Cobalt in the device. This may happen if the European Commission will adopt the proposal to […]

EFORT Open Reviews: High quality instructional review articles on all aspects of orthopaedics and traumatology

EFORT and The British  Editorial  Society of Bone & Joint Surgery are delighted to announce  a new open access journal to be launched in January 2016: EFORT Open Reviews. All articles of EFORT Open Reviews are to be made available open access, with no subscription required and in addition, there will be online CME questions and certification. The Editor-in-Chief  […]

European Arthroplasty Register Network EAR-N

The EFORT Executive Board recognizes that the European Arthroplasty Register (EAR) has been very successful in helping with the implementation of several registers in Europe. Following the increase of activities and subsequent volume, the partnership between EFORT and EAR needs to be adapted and clear reporting and communication lines must be implemented. The EFORT Executive […]

Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection

By Per Kjaersgaard-Andersen, Secretary General, EFORT. A group of over 400 orthopaedic surgeons from world wide, mostly USA, with interest in periprosthetic joint infections meet at the end of July 2013 in Philadelphia for two days to create a consensus statement on the topic. Under the leadership of Thorsten Gehrke, Germany and Javad Parvizi, USA […]

Horizon 2020 integrates research and innovation

Horizon 2020 aims to stimulate growth and jobs across Europe from 2014 to 2020. In comparison to its predecessor, the socalled Framework Program 7 (FP7), Horizon 2020 will make it easier to participate in EU-funded research and innovation projects through a simplified procedure, thus slashing red tape for researchers who want access EU financing. The […]

EFORT 2013: Many highlights, many registrations

The 14th Congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) takes place this year in Istanbul, from June 5 to 8. A city of growing prominence, with a magnificent history and rapidly developing economy, is the ideal location for a congress dedicated to a particularly dynamic field. Appropriately for such […]

EFORT invites you to Istanbul in the early summer of 2013

“One city, two continents” is the perfect description of this wonderful city. Today, Istanbul is a forward-thinking city in an emerging economy, and medical science is one area in which it is especially progressive. That is why EFORT has chosen to hold its 14th Congress in Istanbul  from 5–8 June 2013. It takes a degree […]

European Parliament ITRE Committee vote paves the way for the inclusion of musculoskeletal diseases in the future EU Research Framework Programme, Horizon 2020

On 28 November 2012, the European Parliament ITRE Committee (Committee for Industry, Transport and Energy), voted by large consensus six draft laws related to the EU’s framework research programme Horizon 2020. The programme, which still has to be voted in plenary, and agreed by the Council, will determine EU funding in Research for the next […]

EFORT Executive Board Statement on use of Large-Head Metal-on-Metal Stemmed Total Hip Arthroplasty: “Take a time-out”

Recently, the media, followed by national medical authorities, have raised concerns about problems related to the use of large-head, metal-on-metal, stemmed total hip arthroplasties. At the onset one implant manufacturer with one implant (The ASR hip) was singled out.  The reason was the recall action initiated by this manufacturer and the announced multibillion dollar provision […]

Back to top